Literature DB >> 3109291

Drug-resistant tuberculosis in a southern California hospital. Trends from 1969 to 1984.

I Ben-Dov, G R Mason.   

Abstract

Resistance to one or more antituberculosis drugs was found in 98 of 281 (35%) patients hospitalized at Harbor-UCLA with culture-positive tuberculosis between 1980 and 1984. Resistance to antituberculosis drugs occurred in 23% of patients who had not been previously treated, whereas previously treated patients had a 59% rate of resistance. The overall rates of drug resistance had not significantly changed from prior studies at this hospital. Drug resistance was also found in patients with extrapulmonary disease, but tended to be less frequent than in patients with pulmonary disease. An analysis of risk factors for drug resistance rates revealed no significant differences between Hispanics, blacks, Caucasians, and Asians. Age was not found to be a significant factor to predict resistance rates. Resistance rates were higher if cavitary disease was present on radiographs. Furthermore, cavitary disease seems to be additive to prior antituberculosis treatment as a risk factor for drug resistance. Patients who had both of these risk factors present had 71% incidence of drug resistance rates.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3109291     DOI: 10.1164/arrd.1987.135.6.1307

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  11 in total

Review 1.  Drug-resistant tuberculosis.

Authors:  R Long
Journal:  CMAJ       Date:  2000-08-22       Impact factor: 8.262

2.  Problems with old diseases related to social and pharmaceutical industry situations.

Authors:  H C Neu
Journal:  Bull N Y Acad Med       Date:  1988 Jul-Aug

3.  Which aminoglycoside or fluoroquinolone is more active against Mycobacterium tuberculosis in mice?

Authors:  N Lounis; B Ji; C Truffot-Pernot; J Grosset
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

Review 4.  Treatment and prevention of multidrug-resistant tuberculosis.

Authors:  I Bastian; R Colebunders
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

5.  Cell wall and membrane changes associated with ethambutol resistance in Mycobacterium tuberculosis H37Ra.

Authors:  M Sareen; G K Khuller
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

6.  Clinical prediction rule for stratifying risk of pulmonary multidrug-resistant tuberculosis.

Authors:  Dalila Martínez; Gustavo Heudebert; Carlos Seas; German Henostroza; Martin Rodriguez; Carlos Zamudio; Robert M Centor; Cesar Herrera; Eduardo Gotuzzo; Carlos Estrada
Journal:  PLoS One       Date:  2010-08-11       Impact factor: 3.240

7.  Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice.

Authors:  V Lalande; C Truffot-Pernot; A Paccaly-Moulin; J Grosset; B Ji
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

Review 8.  Tuberculosis in the AIDS era.

Authors:  K A Sepkowitz; J Raffalli; L Riley; T E Kiehn; D Armstrong
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

9.  The incidence of drug resistant tuberculosis in 1279 Korean patients.

Authors:  H Yum; Y Song; S Jeon; S Choi; B Lee; D Kim
Journal:  Korean J Intern Med       Date:  1995-01       Impact factor: 2.884

10.  Differences between Risk Factors Associated with Tuberculosis Treatment Abandonment and Mortality.

Authors:  Nathália Mota de Faria Gomes; Meire Cardoso da Mota Bastos; Renata Magliano Marins; Aline Alves Barbosa; Luiz Clóvis Parente Soares; Annelise Maria de Oliveira Wilken de Abreu; João Tadeu Damian Souto Filho
Journal:  Pulm Med       Date:  2015-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.